Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 10:31 AM ET

Date/Time Source News Release
05/29/2025 08:00 AM EDT GlobeNewswire Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
05/19/2025 08:00 AM EDT GlobeNewswire SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology
05/13/2025 04:00 PM EDT GlobeNewswire Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates
05/06/2025 04:30 PM EDT GlobeNewswire Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
05/06/2025 08:00 AM EDT GlobeNewswire Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
04/02/2025 08:00 AM EDT GlobeNewswire Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
03/28/2025 07:30 AM EDT GlobeNewswire Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
03/07/2025 08:30 AM EST GlobeNewswire Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
03/06/2025 04:00 PM EST GlobeNewswire Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
03/04/2025 04:15 PM EST GlobeNewswire Lexicon Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
Page

Additional News

As of June 3, 2025 • 10:31 AM ET

Date/Time Source News Release
06/02/2025 10:53 AM EDT Zacks MRK's ADC Drug Combo Shows Antitumor Activity in Lymphoma Study
05/30/2025 10:20 AM EDT Zacks NTLA Stock Down as Patient Faces Adverse Event in Gene Therapy Study
05/30/2025 08:59 AM EDT Zacks IMVT Q4 Loss Narrower Than Expected, Stock Up, Pipeline in Focus
05/29/2025 11:44 AM EDT Zacks BMY's Opdivo SC Gets EU Nod for Multiple Solid Tumor Indications
05/29/2025 10:50 AM EDT Zacks CADL Up as FDA Grants RMAT Status to CAN-2409 in Prostate Cancer
05/28/2025 11:09 AM EDT Zacks RCKT Stock Tanks on Patient Death in Danon Disease Study
05/28/2025 11:07 AM EDT Zacks TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate
05/28/2025 10:43 AM EDT Zacks VSTM Stock Soars 22% in a Month on Ovarian Cancer Combo Drug Approval
05/27/2025 10:46 AM EDT Zacks AZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder Cancer
05/26/2025 11:44 AM EDT Zacks GSK Gets CHMP Nod for Blenrep Combos in Multiple Myeloma
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.